|
20 Feb 2007 |
CeNeS Pharmaceuticals plc: Successful Phase III results announced on Lead Product M6G
|
|
20 Feb 2007 |
Cardiome and Astellas Announce Acceptance of NDA for Review
|
|
17 Feb 2007 |
GPC Biotech Submits NDA for Lead Oncology Drug Candidate Satraplatin
|
|
17 Feb 2007 |
Anti-HIV Medication PREZISTA(TM) Receives Conditional Marketing Authorization in the European Union
|
|
17 Feb 2007 |
Positive outcome from pre-Phase III FDA and EMEA scientific advice meetings for VitorTM
|
|
17 Feb 2007 |
Roche files application in Europe for Tamiflu 30 and 45 mg capsules
|
|
17 Feb 2007 |
InSite Vision Announces License Agreement With Inspire Pharmaceuticals
|
|
17 Feb 2007 |
Gilead's New Drug Application for Ambrisentan Receives Priority Review Status
|
|
16 Feb 2007 |
OXiGENE Announces Positive Results from its Phase II CA4P Clinical Trial in Myopic Macular Degeneration (MMD-213)
|
|
16 Feb 2007 |
Positive Results with Lacosamide in Diabetic Neuropathic Pain in Phase III trial
|
|
16 Feb 2007 |
ARIAD Announces Global Phase 3 Clinical Trial Plans for AP23573 With Sarcoma Alliance and Achievement of Key Regulatory Milestones at Investor & Analyst Day
|
|
16 Feb 2007 |
FDA Accepts Two Supplemental New Drug Applications to Expand the U.S. Labeling for JANVUIA
|
|
16 Feb 2007 |
Alteon's Alagebrium Demonstrates Cardiovascular Activity In Recently Published Report Indicating Potential Wide-Ranging Benefits In Cardiovascular Diseases
|
|
16 Feb 2007 |
NanoBio(R) Corporation Initiates Phase 2b Clinical Trial for Herpes Labialis Treatment
|
|
16 Feb 2007 |
Elite Pharmaceuticals Provides Positive Clinical Update
|
|
15 Feb 2007 |
Activbiotics Announces Initiation Of Phase II Study In Carotid Atherosclerosis
|
|
15 Feb 2007 |
GW and Otsuka Announce Major Long Term Strategic Cannabinoid Alliance
|
|
15 Feb 2007 |
Pharmacopeia's DARA Program for Hypertension and Diabetic Nephropathy Advances Into Phase 1 Clinical Trials
|
|
15 Feb 2007 |
Infinity and MedImmune Initiate Phase I/II Clinical Trial of IPI-504 for Patients With Non-Small Cell Lung Cancer
|
|
14 Feb 2007 |
Rigel Announces Initiation of Phase 1 Study Evaluating R763 in Hematological Malignancies
|
|
14 Feb 2007 |
Pfizer's Maraviroc to Receive Accelerated Regulatory Reviews in the U.S. and Europe
|
|
14 Feb 2007 |
InSite Vision Announces Positive Top-Line Safety Results from Phase 1 AzaSite Plus Clinical Study
|
|
14 Feb 2007 |
Further Validation of NNZ-2566 as a Traumatic Brain Injury Treatment
|
|
14 Feb 2007 |
Somaxon Provides Update on SILENOR(TM) Preclinical Program
|
|
14 Feb 2007 |
SIGA Begins Second Human Safety Trial of Its Lead Smallpox Drug
|
